Summary of Key Information:

Reporting Period (Quarter/Year): Not Specified

Nature of Filing / Announcement: Outcome of Board Meeting under SEBI LODR Regulations 30 & 33

Date of Board Meeting / Approval: 22nd August, 2026

Audit Opinion: Not Specified

Auditor's Comment: Not Specified

Key Financial Highlights:

Not Specified

Standalone Results:

Not Specified

Consolidated Results:

Not Specified

Segment-wise Performance:

Not Specified

Corporate Actions:

  • Proposed change of company name from "Shukra Pharmaceuticals Limited" to "Shukra Medtech Limited" subject to approval of Central Registration Centre (CRC), Ministry of Corporate Affairs, other relevant authorities, and shareholders
  • Recommended alteration in main objects of the Company and consequential alteration in Main Object Clause of Memorandum of Association
  • Register of Members & Share Transfer Books will remain closed from 19 September, 2026 to 25 September, 2026 (both days inclusive) for the 33rd AGM

Regulatory Disclosures:

  • Appointment of CS Rupal Patel as Scrutinizer to scrutinize e-voting process
  • Approval of Director's Report for year ended March 31, 2026
  • Adoption of Secretarial Audit Report pursuant to Section 204(1) of Companies Act, 2013 for year ended March 31, 2026
  • Convening 33rd Annual General Meeting on 25th September, 2026 at 12.00 P.M. (IST) through Video Conferencing
  • Appointment of Mrs. Rupal Patel, Practicing Company Secretary as Scrutinizer of Remote E-voting and voting at AGM

Other Significant Information:

Proposed New Business Objects:

  • To carry on business of research, design, development, engineering, manufacturing, testing, validation, installation, commissioning, licensing, and commercialization of medical devices, medical equipment, diagnostic systems, surgical instruments, surgical robotic systems, implantable devices, wearable healthcare devices, artificial intelligence-based healthcare technologies, healthcare software, digital health platforms, telemedicine systems, hospital automation solutions
  • To act as manufacturers, buyers, sellers, importers, exporters, distributors, and dealers in all kinds of medical technology products, healthcare devices, diagnostic equipment, robotic surgery systems, AI-driven healthcare solutions
  • To enter into strategic alliances, collaborations, technical partnerships, joint ventures, licensing arrangements, technology transfer agreements with Indian and foreign companies, institutions, research organizations, hospitals, universities, and governments
  • To establish, acquire, develop, construct, operate, maintain Medical Technology Parks, healthcare industrial clusters, research laboratories, incubation centers, innovation hubs, manufacturing units
  • To provide installation, commissioning, maintenance, repair, calibration, validation, technical support, consulting, training services for medical devices and robotic surgical systems
  • To develop, acquire, license, market, maintain, and operate healthcare software, artificial intelligence systems, machine learning applications, cloud-based healthcare platforms, electronic medical record systems, hospital information systems